Guardian Pharmacy Services (GRDN) EPS (Weighted Average and Diluted) (2024 - 2026)

Guardian Pharmacy Services has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting $0.21 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.21, up 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.83 (up 100.08% YoY), and the FY2025 annual result was $0.78, up 144.07% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.21 for Q1 2026 at Guardian Pharmacy Services, down from $0.33 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.33 in Q4 2025 to a low of -$2.0 in Q3 2024.
• The 3-year median for EPS (Weighted Average and Diluted) is $0.15 (2025), against an average of -$0.11.
• Across the five-year window, EPS (Weighted Average and Diluted) surged 107.5% in 2025 and jumped 40.0% in 2026, its largest moves.
• Guardian Pharmacy Services' EPS (Weighted Average and Diluted) stood at $0.23 in 2024, then jumped by 43.48% to $0.33 in 2025, then sank by 36.36% to $0.21 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.21 (Q1 2026), $0.33 (Q4 2025), and $0.15 (Q3 2025), per Business Quant data.